96825-80-8

Upstream product

• 96825-71-7 2-[6-(4-Chloro-phenyl)-4-oxo-1,4-dihydro-pyridazin-3-yl]-benzoic acid 
• 96825-76-2 3-(4-Chloro-phenyl)-5H-pyridazino[4,3-c]isoquinolin-6-one 
• 96825-73-9 2-(4-Chloro-phenyl)-10-oxa-3,4-diaza-phenanthren-9-one 

Downstream Products

• 96825-94-4 1-{[3-(4-Chloro-phenyl)-pyridazino[4,3-c]isoquinolin-6-yl]-methyl-amino}-propan-2-ol 
• 96825-93-3 [3-(4-Chloro-phenyl)-pyridazino[4,3-c]isoquinolin-6-yl]-dimethyl-amine 
• 96825-95-5 3-(4-Chlorophenyl)-N,N-bis (2-methoxyethyl)pyridazino[4,3-c]isoquinolin-6-amine 
• 96825-96-6 3-(4-Chlorophenyl)-6-(l-pyrrolidinyl)pyridazino[4,3-c]isoquinoline 

Relevant academic research and scientific papers

Pyridazino[4,3-c]-isoquinolines having anti-anxiety activity

The present invention is directed to pyridazino[4,3-c]isoquinolines of Formula I STR1 wherein R represents methyl, phenyl or substituted phenyl groups, R 1 represents inter alia amino or substituted amino, alkoxy or cycloalkoxy groups, having pharmacologi

Benzodiazepine receptor binding and anticonflict activity in a series of 3,6-disubstituted pyridazino[4,3-c]isoquinolines devoid of anticonvulsant properties

A series of 3,6-disubstituted pyridazino [4,3-c]isoquinolines were synthesized and tested for their ability to inhibit the binding of [3H]diazepam to rat brain receptors in vitro. Compounds bearing a phenyl, 4-methyoxyphenyl, or methyl group at